Self-propelled ferroptosis nanoinducer for enhanced cancer therapy

Ferroptosis is a newly proposed type of programmed cell death, which has been associated with a variety of diseases including tumors. Researchers have thereby presented nanoplatforms to mediate ferroptosis for anti-cancer therapy. However, the development of ferroptosis-based nanotherapeutics is gen...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenxin Xu, Hao Tian, Yanzhen Song, Hanfeng Qin, Junbin Gao, Yichi Chen, Weichang Huang, Lin Lin, Haixin Tan, Yicheng Ye, Xiaoting Zhang, Daniela A Wilson, Guang Yang, Fei Peng, Yingfeng Tu
Format: Article
Language:English
Published: IOP Publishing 2025-01-01
Series:International Journal of Extreme Manufacturing
Subjects:
Online Access:https://doi.org/10.1088/2631-7990/ada838
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589694525767680
author Wenxin Xu
Hao Tian
Yanzhen Song
Hanfeng Qin
Junbin Gao
Yichi Chen
Weichang Huang
Lin Lin
Haixin Tan
Yicheng Ye
Xiaoting Zhang
Daniela A Wilson
Guang Yang
Fei Peng
Yingfeng Tu
author_facet Wenxin Xu
Hao Tian
Yanzhen Song
Hanfeng Qin
Junbin Gao
Yichi Chen
Weichang Huang
Lin Lin
Haixin Tan
Yicheng Ye
Xiaoting Zhang
Daniela A Wilson
Guang Yang
Fei Peng
Yingfeng Tu
author_sort Wenxin Xu
collection DOAJ
description Ferroptosis is a newly proposed type of programmed cell death, which has been associated with a variety of diseases including tumors. Researchers have thereby presented nanoplatforms to mediate ferroptosis for anti-cancer therapy. However, the development of ferroptosis-based nanotherapeutics is generally hindered by the limited penetration depth in tumors, poor active pharmaceutical ingredient (API) loading content and the systemic toxicity. Herein, self-propelled ferroptosis nanoinducers composed of two endogenous proteins, glucose oxidase and ferritin, are presented to show enhanced tumor inhibition via ferroptosis while maintaining high API and biocompatibility. The accumulation of our proteomotors at tumor regions is facilitated by the active tumor-targeting effect of ferritin. The enhanced diffusion of proteomotors is then actuated by efficiently decomposing glucose into gluconic acid and H _2 O _2 , leading to deeper penetration and enhanced uptake into tumors. Under the synergistic effect of glucose oxidase and ferritin, the equilibrium between reactive oxygen species and GSH is damaged, leading to lipid peroxidation. As a result, by inducing ferroptosis, our self-propelled ferroptosis nanoinducers exhibit enhanced tumor inhibitory effects. This work paves a way for the construction of a biocompatible anticancer platform with enhanced diffusion utilizing only two endogenous proteins, centered around the concept of ferroptosis.
format Article
id doaj-art-4f5ffb5cc56049a7bbebb6d0ffe54778
institution Kabale University
issn 2631-7990
language English
publishDate 2025-01-01
publisher IOP Publishing
record_format Article
series International Journal of Extreme Manufacturing
spelling doaj-art-4f5ffb5cc56049a7bbebb6d0ffe547782025-01-24T09:09:25ZengIOP PublishingInternational Journal of Extreme Manufacturing2631-79902025-01-017303550110.1088/2631-7990/ada838Self-propelled ferroptosis nanoinducer for enhanced cancer therapyWenxin Xu0Hao Tian1Yanzhen Song2Hanfeng Qin3Junbin Gao4Yichi Chen5Weichang Huang6Lin Lin7Haixin Tan8Yicheng Ye9Xiaoting Zhang10Daniela A Wilson11Guang Yang12Fei Peng13Yingfeng Tu14https://orcid.org/0000-0003-2605-0172NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaDepartment of Stomatology, Nanfang Hospital, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaInstitute for Molecules and Materials, Radboud University , Nijmegen 6525 AJ, The NetherlandsGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People’s Hospital (Zhuhai hospital affiliated with Jinan University) , Zhuhai 519000, People’s Republic of ChinaSchool of Materials Science and Engineering, Sun Yat-Sen University , Guangzhou 510275, People’s Republic of ChinaNMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University , Guangzhou 510515, People’s Republic of ChinaFerroptosis is a newly proposed type of programmed cell death, which has been associated with a variety of diseases including tumors. Researchers have thereby presented nanoplatforms to mediate ferroptosis for anti-cancer therapy. However, the development of ferroptosis-based nanotherapeutics is generally hindered by the limited penetration depth in tumors, poor active pharmaceutical ingredient (API) loading content and the systemic toxicity. Herein, self-propelled ferroptosis nanoinducers composed of two endogenous proteins, glucose oxidase and ferritin, are presented to show enhanced tumor inhibition via ferroptosis while maintaining high API and biocompatibility. The accumulation of our proteomotors at tumor regions is facilitated by the active tumor-targeting effect of ferritin. The enhanced diffusion of proteomotors is then actuated by efficiently decomposing glucose into gluconic acid and H _2 O _2 , leading to deeper penetration and enhanced uptake into tumors. Under the synergistic effect of glucose oxidase and ferritin, the equilibrium between reactive oxygen species and GSH is damaged, leading to lipid peroxidation. As a result, by inducing ferroptosis, our self-propelled ferroptosis nanoinducers exhibit enhanced tumor inhibitory effects. This work paves a way for the construction of a biocompatible anticancer platform with enhanced diffusion utilizing only two endogenous proteins, centered around the concept of ferroptosis.https://doi.org/10.1088/2631-7990/ada838endogenous proteinbiocompatibilityself-propelled proteomotorsenhanced diffusionferroptosis nanoinducertargeted tumor therapy
spellingShingle Wenxin Xu
Hao Tian
Yanzhen Song
Hanfeng Qin
Junbin Gao
Yichi Chen
Weichang Huang
Lin Lin
Haixin Tan
Yicheng Ye
Xiaoting Zhang
Daniela A Wilson
Guang Yang
Fei Peng
Yingfeng Tu
Self-propelled ferroptosis nanoinducer for enhanced cancer therapy
International Journal of Extreme Manufacturing
endogenous protein
biocompatibility
self-propelled proteomotors
enhanced diffusion
ferroptosis nanoinducer
targeted tumor therapy
title Self-propelled ferroptosis nanoinducer for enhanced cancer therapy
title_full Self-propelled ferroptosis nanoinducer for enhanced cancer therapy
title_fullStr Self-propelled ferroptosis nanoinducer for enhanced cancer therapy
title_full_unstemmed Self-propelled ferroptosis nanoinducer for enhanced cancer therapy
title_short Self-propelled ferroptosis nanoinducer for enhanced cancer therapy
title_sort self propelled ferroptosis nanoinducer for enhanced cancer therapy
topic endogenous protein
biocompatibility
self-propelled proteomotors
enhanced diffusion
ferroptosis nanoinducer
targeted tumor therapy
url https://doi.org/10.1088/2631-7990/ada838
work_keys_str_mv AT wenxinxu selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT haotian selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT yanzhensong selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT hanfengqin selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT junbingao selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT yichichen selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT weichanghuang selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT linlin selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT haixintan selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT yichengye selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT xiaotingzhang selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT danielaawilson selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT guangyang selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT feipeng selfpropelledferroptosisnanoinducerforenhancedcancertherapy
AT yingfengtu selfpropelledferroptosisnanoinducerforenhancedcancertherapy